Anavex Life Sciences
AVXL
#7563
Rank
C$0.54 B
Marketcap
C$6.08
Share price
-1.12%
Change (1 day)
-42.96%
Change (1 year)

Anavex Life Sciences (AVXL) - Total assets

Total assets on the balance sheet as of June 2025 : C$0.14 Billion

According to Anavex Life Sciences 's latest financial reports the company's total assets are C$0.14 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Anavex Life Sciences - Total assets on balance sheet (from 2005 to 2025)

Total assets by year

Year Total assets Change
2024-09-30C$0.18 B-12.6%
2023-09-30C$0.20 B-0.28%
2022-09-30C$0.21 B2.64%
2021-09-30C$0.20 B346.03%
2020-09-30C$45.95 M37.02%
2019-09-30C$33.54 M-0.32%
2018-09-30C$33.65 M-2.56%
2017-09-30C$34.53 M176.2%
2016-09-30C$12.5 M-39.31%
2015-09-30C$20.6 M150.01%
2014-09-30C$8.24 M1928.68%
2013-09-30C$0.4 M3037.73%
2012-09-30C$0.01 M-93.85%
2011-09-30C$0.21 M-38.11%
2010-09-30C$0.34 M-23.26%
2009-09-30C$0.44 M5673.53%
2008-09-30C$0 M30851.67%
2007-09-30C$0 M-99.82%
2006-09-30C$0.01 M1119.25%
2005-09-30C$0 M-96.77%
2004-09-30C$0.03 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Ligand Pharmaceuticals
LGND
C$2.04 B 1,341.71%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
C$0.61 B 335.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
C$1.13 B 704.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
C$5.15 M-96.36%๐Ÿ‡บ๐Ÿ‡ธ USA